Viatris company profile
Company profile
Viatris has 30,000 employees and is headquartered in Canonsburg, United States.
Viatris Inc. is based in Canonsburg, Pennsylvania, and has existed since its founding in 1961. Together with its subsidiaries, the healthcare company develops and sells prescription brand drugs, generic drugs, complex generics and biosimilars in areas such as cardiovascular, CNS and anesthesia, diabetes and metabolism, oncology, and respiratory and allergy. Its brands include Lipitor, Viagra, Lyrica and EpiPen Auto-Injector, supplied as oral solid doses, injectables and complex dosage forms to pharmacies, wholesalers, payers, insurers, governments and institutions. Operations span North America, Europe, China, Japan, Australia, Africa, Latin America and the Middle East, organized into four segments: Developed Markets, Greater China, JANZ and Emerging Markets.
In the fiscal year ended December 2025, Viatris reported revenue of USD 14.3 billion, down 3.0% from the previous year, and a net loss of USD 3.5 billion. The United States accounted for 12.7% of revenue and China for 8.8%. The company had 30,000 employees.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Headquarters
- Robert J. Coury Global Center, 15317, Canonsburg
- Employees
- 30,000
- Chief executive
- Scott Smith
- Founded
- 1961
- Fiscal year
- January - December
- Listing
- VTRS · NASDAQ
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US92556V1061
- Website
- viatris.com
Viatris and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| ViatrisVTRS | United States | $23.58B | 30,000 | — | — |
| United TherapeuticsUTHR | United States | $25.04B | 1,400 | 39.4% | 22.2 |
| Neurocrine BiosciencesNBIX | United States | $16.73B | 2,500 | 26.6% | 24.5 |
| ZoetisZTS | United States | $33.92B | 14,500 | 37.9% | 14.1 |
| Teva Pharmaceutical IndustriesTEVA | United States | $49.67B | 31,173 | 19.8% | 99.0 |
| Hims & Hers HealthHIMS | United States | $4.13B | 2,442 | -6.4% | — |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
